Sarepta Therapeutics, Inc.SRPTNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$218.08M
↑ 166% above average
Average (9y)
$-331.76M
Historical baseline
Range
High:$218.08M
Low:$-705.56M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $218.08M | +181.4% |
| 2023 | $-267.82M | +50.1% |
| 2022 | $-536.20M | -16.6% |
| 2021 | $-459.71M | +18.5% |
| 2020 | $-564.16M | +20.0% |
| 2019 | $-705.56M | -105.3% |
| 2018 | $-343.63M | -100.2% |
| 2017 | $-171.64M | +35.7% |
| 2016 | $-266.73M | -21.1% |
| 2015 | $-220.18M | - |